Mitsunobu Kitamura1, Tobias Schmidt1, Karl-Heinz Kuck1, Christian Frerker2. 1. Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Germany. 2. Department of Cardiology, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Germany. c.frerker@asklepios.com.
Abstract
PURPOSE OF REVIEW: Interventional techniques have been developed for a wide spectrum of mechanisms of heart failure (HF), especially in valvular heart disease and cardiomyopathies (ischaemic cardiomyopathy and hypertrophic cardiomyopathy). In this article, we review recent reports on catheter interventions to treat patients with HF. RECENT FINDINGS: Direct modification using the Parachute device and the REVIVENT-TC device for patients with impaired left ventricle with large infarct scars improves geometry and haemodynamic efficiency, resulting in a reduction of HF symptoms. Interatrial shunt therapy improves symptoms and quality of life in HF patients. Uniquely, left ventricular outflow tract obstruction has also been targeted in patients with transcatheter mitral valve implantation. For advanced stage HF patients with prohibitively high surgical risk, emerging transcatheter interventions make it possible to modify life-limiting symptoms. Further results on HF interventions are expected from ongoing clinical trials.
PURPOSE OF REVIEW: Interventional techniques have been developed for a wide spectrum of mechanisms of heart failure (HF), especially in valvular heart disease and cardiomyopathies (ischaemic cardiomyopathy and hypertrophic cardiomyopathy). In this article, we review recent reports on catheter interventions to treat patients with HF. RECENT FINDINGS: Direct modification using the Parachute device and the REVIVENT-TC device for patients with impaired left ventricle with large infarct scars improves geometry and haemodynamic efficiency, resulting in a reduction of HF symptoms. Interatrial shunt therapy improves symptoms and quality of life in HF patients. Uniquely, left ventricular outflow tract obstruction has also been targeted in patients with transcatheter mitral valve implantation. For advanced stage HF patients with prohibitively high surgical risk, emerging transcatheter interventions make it possible to modify life-limiting symptoms. Further results on HF interventions are expected from ongoing clinical trials.
Entities:
Keywords:
Heart failure interventions; Interatrial shunt device; Ischaemic cardiomyopathy; Left ventricular outflow tract obstruction; Left ventricular reconstruction
Authors: Max Liebregts; Lothar Faber; Morten K Jensen; Pieter A Vriesendorp; Jaroslav Januska; Jan Krejci; Peter R Hansen; Hubert Seggewiss; Dieter Horstkotte; Radka Adlova; Henning Bundgaard; Jurriën M Ten Berg; Josef Veselka Journal: JACC Cardiovasc Interv Date: 2017-06-12 Impact factor: 11.195
Authors: Lars Søndergaard; Vivek Reddy; David Kaye; Filip Malek; Antony Walton; Martin Mates; Olaf Franzen; Petr Neuzil; Nikolaj Ihlemann; Finn Gustafsson Journal: Eur J Heart Fail Date: 2014-06-24 Impact factor: 15.534
Authors: Robert E Michler; Jean L Rouleau; Hussein R Al-Khalidi; Robert O Bonow; Patricia A Pellikka; Gerald M Pohost; Thomas A Holly; Jae K Oh; Francois Dagenais; Carmelo Milano; Krzysztof Wrobel; Jan Pirk; Imtiaz S Ali; Robert H Jones; Eric J Velazquez; Kerry L Lee; Marisa Di Donato Journal: J Thorac Cardiovasc Surg Date: 2012-10-27 Impact factor: 5.209